Developer docs
API playgroundTry for free, no card

Search company profiles

KeraFAST

Full company profile

uuid00051nn

Namestring
KeraFAST
Legal namestring
Vector Laboratories, Inc.
Websiteurl
kerafast.com
Company typeenum
Private
Founded yearint
2011
Descriptiontext

Kerafast is a Boston-based e-commerce marketplace that connects academic life science researchers with unique laboratory-made reagents contributed by investigators at 200+ institutions worldwide. The platform offers more than eleven product categories, including antibodies, plasmids, lentiviruses, virus vectors (including a proprietary VSV-G Pseudotyped ΔG system), cell lines, proteins, and labeling/detection reagents, with specialty product lines targeting infectious disease, gene delivery, and structural biology research. Its operating model bypasses traditional Material Transfer Agreement (MTA) processes through a self-serve catalog and global shipping, while a "Reagents for the Greater Good" royalty mechanism returns a share of each sale to the contributing scientist and institution, supported by formal provider programs such as Kerafast Partners (KFP) and Kerafast Fellows.

Commercially, Kerafast generates revenue primarily through direct transactional reagent sales at unit prices ranging from $132 to over $1,400, supplemented by higher-margin services such as custom lentivirus production and ELISA/multiplex assay services. Customers span academic institutions, pharmaceutical/biotech firms, and government agencies (including the FDA and Department of Veterans Affairs), with global reach across North America, Europe, the Middle East, and beyond. Since 2018, Kerafast has operated under Vector Laboratories, Inc., following its merger with UK-based Absolute Antibody; the broader Vector portfolio also includes Everest Biotech, Exalpha Biologicals, Nordic-MUbio, and LifeSpan BioSciences. The company is private, has not raised institutional capital since 2016, and runs a lean organization of 11-50 employees with a digital-first, self-serve go-to-market motion and email/blog marketing channels.

Short descriptiontext

Kerafast is a Boston-based e-commerce marketplace enabling life science researchers worldwide to discover, purchase, and supply unique academic reagents, bypassing traditional MTA processes through a self-serve platform serving 200+ contributing institutions.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersBoston, United States
HQ citystring
Boston
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
research reagent marketplace, life science reagents, antibody distribution, virus vectors, academic reagent supply
Industry1 code
PRIMARYBPAMAGAL
Omnichannel Commerce & Click-and-Collect Platforms
Business & Public Services/Web, Mobile & Digital Platforms/E-commerce Marketplaces & Shopping Platforms
NAICS code1 code
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
SIC code1 code
  • Wholesale-Drugs, Proprietaries & Druggists' Sundries5122
Product category
Life Science Research Reagents
Social media profiles3 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1Reagent Product Sales
TypeTransaction Fee
Description

Direct sales of research reagents including antibodies, cell lines, plasmids, lentiviruses, virus vectors, proteins, and other laboratory materials. Transaction-based pricing with listed catalog prices.

kerafast.com
2Royalty Revenue Sharing
TypeMarketplace Commission
Description

Generous royalty payments returned to scientists and institutions that contribute reagents to the platform, funded from every sale.

kerafast.com
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Operations, Marketing or Sales, Technology or R&D, Personnel, Supply Chain
Pricing details1 tier
1Individual reagent products sold at catalog prices
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Antibodies: $362-$662; Plasmids: $132-489; Lentiviruses: $578-$1,434; Cell lines: $410; Virus products: $1,177+

kerafast.com
GTM typeB2B
B2B
Offering typeDigital Commerce or Conte…
Digital Commerce or Content
Core offering1 text field

KeraFAST operates an online marketplace that aggregates unique, hard-to-obtain research reagents contributed by academic laboratories worldwide and makes them directly purchasable by life science researchers. The platform bypasses traditional Material Transfer Agreement (MTA) processes, offering reagents across categories including antibodies, cell lines, plasmids, lentiviruses, VSV vectors, proteins, enzymes, and kits. Proceeds from sales are shared with contributing laboratories via a royalty model branded 'Reagents for the Greater Good'.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

KeraFAST is a Boston-based reagent company offering an extensive portfolio of unique research products sourced from university laboratories worldwide. The company operates as a multi-category reagent marketplace featuring over 11 product types including Antibodies & Secondary Detection Reagents, Buffers & Chemicals, Cell Culture & Transfection Reagents, Cells & Tissue Samples, DNA Vectors/Clones/Nucleic Acids, Kits & Assays, Labeling & Detection Products, PCR Products, Proteins/Enzymes/Peptides, Virus Vectors and Particles, and Services. Core product lines include Vesicular Stomatitis Virus (VSV) reagents (antibodies, cell lines, plasmids, pseudotyped viruses), Premade Lentiviruses, and the VSV-G Pseudotyped ΔG Virus System for producing chimeric viruses. The company also offers Custom Lentivirus Production services. Products are sourced from academic researchers and distributed through an online platform, with proceeds returning to the providing laboratories.

Product and service8 records
1Antibodies & Secondary Detection Reagents
CategoryLife Science Research Reagents
Description

Catalog of primary antibodies, secondary antibodies, antibody labeling reagents, tag and loading control antibodies, and hybridomas supplied by academic laboratories for life science research applications.

2Buffers & Chemicals
CategoryLife Science Research Reagents
Description

Laboratory buffers, compounds, isolated natural products, and unique chemistry reagents sourced from academic providers for research applications.

3Cell Culture & Transfection Reagents
CategoryLife Science Research Reagents
Description

Reagents for cell culture maintenance and genetic transfection experiments, distributed via the marketplace.

4Cells & Tissue Samples
CategoryLife Science Research Reagents
Description

Bacterial cells, eukaryotic cells, primary cells, stem cells, and tissue samples supplied by academic laboratories for research use.

5DNA Vectors, Clones, Purified Nucleic Acids & Libraries
CategoryLife Science Research Reagents
Description

GFP-dependent transcription system plasmids, general plasmids, and purified nucleic acid reagents for molecular biology research.

6Kits & Assays
CategoryLife Science Research Reagents
Description

Complete assay kits for various research applications, assembled from reagents contributed by academic laboratories.

7Labeling & Detection Products
CategoryLife Science Research Reagents
Description

Click chemistry probes, biotin-related reagents, fluorescent probes, nanoparticles, reactive dyes, GFP reagents, chelators, and protein conjugation kits for detection workflows.

8PCR Products
Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership2 partners
1Absolute Antibody
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2018-01-01
Description

UK-based company merged with Kerafast in 2018 with shared commitment to improving selection of research tools. Absolute Antibody focuses on recombinant antibody technology. Kerafast handles North and South American sales and customer service as well as global marketing for Absolute Antibody.

kerafast.com
Strategic tierCoreTypeTechnology or Integration
Description

Kerafast is owned and operated by Vector Laboratories Inc. Part of the Vector family including Everest Biotech, Exalpha Biologicals, Nordic-MUbio, LifeSpan BioSciences, Inc., and Absolute Antibody, Ltd.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Non-profit plasmid repository operating a similar community-driven reagent sharing model for life science researchers. Highly comparable as a peer-to-peer reagent exchange marketplace serving academic scientists, though Addgene focuses specifically on plasmids and associated tools.

TypeBroad incumbent
Description

Established biological resource center offering authenticated cell lines, microorganisms, and related services. Comparable as a supplier of standardized biological materials to research institutions, though ATCC operates as a traditional distributor rather than a marketplace.

TypeBroad incumbent
Description

Largest life science reagent and instrument supplier globally, offering extensive catalogs across antibodies, cell culture, and molecular biology products. Represents the dominant incumbent against which Kerafast's marketplace model competes for research reagent budgets.

TypeBroad incumbent
Description

Major chemical, biochemical, and reagent distributor under Merck KGaA. Comparable as a broad-line reagent supplier to academic and pharmaceutical researchers with established logistics and brand recognition.

TypeBroad incumbent
Description

Life science reagent and instrument provider spanning proteins, antibodies, ELISA kits, and cell/gene therapy workflow tools. Comparable as a multi-category reagent supplier serving academic and pharma researchers with overlapping product categories.

TypeBroad incumbent
Description

Major specialty antibody supplier serving life science research. Comparable as a high-quality reagent distributor with strong academic customer base, though Abcam focuses on antibodies rather than operating a broad marketplace model.

TypeBroad incumbent
Description

Specialty antibody and reagent provider for cell signaling research. Comparable as a research-grade reagent supplier with strong academic and pharma relationships, particularly in antibody products that overlap with Kerafast's catalog.

8Santa Cruz Biotechnology
TypeDirect peer
Description

Antibody and reagent supplier serving academic and pharmaceutical researchers across multiple research areas. Comparable as a direct competitor in antibody and reagent sales to life science researchers, with overlapping product categories.

9Absolute Antibody
TypeOthers
Description

Recombinant antibody technology provider that merged with Kerafast in 2018 under Vector Laboratories. Comparable as a sister company operating within the same Vector Labs portfolio with overlapping customer base and shared infrastructure.

TypeEmerging player
Description

Non-profit biomedical research organization maintaining cell line and DNA repositories for the research community. Comparable as a specialized biorepository serving academic researchers, though Coriell is more focused on biobanking than an active marketplace.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers6 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature2 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds4 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors2 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

KeraFAST

Life Science Research Reagentskerafast.com

Kerafast is a Boston-based e-commerce marketplace enabling life science researchers worldwide to discover, purchase, and supply unique academic reagents, bypassing traditional MTA processes through a self-serve platform serving 200+ contributing institutions.

What KeraFAST does

Kerafast is a Boston-based e-commerce marketplace that connects academic life science researchers with unique laboratory-made reagents contributed by investigators at 200+ institutions worldwide. The platform offers more than eleven product categories, including antibodies, plasmids, lentiviruses, virus vectors (including a proprietary VSV-G Pseudotyped ΔG system), cell lines, proteins, and labeling/detection reagents, with specialty product lines targeting infectious disease, gene delivery, and structural biology research. Its operating model bypasses traditional Material Transfer Agreement (MTA) processes through a self-serve catalog and global shipping, while a "Reagents for the Greater Good" royalty mechanism returns a share of each sale to the contributing scientist and institution, supported by formal provider programs such as Kerafast Partners (KFP) and Kerafast Fellows.

Commercially, Kerafast generates revenue primarily through direct transactional reagent sales at unit prices ranging from $132 to over $1,400, supplemented by higher-margin services such as custom lentivirus production and ELISA/multiplex assay services. Customers span academic institutions, pharmaceutical/biotech firms, and government agencies (including the FDA and Department of Veterans Affairs), with global reach across North America, Europe, the Middle East, and beyond. Since 2018, Kerafast has operated under Vector Laboratories, Inc., following its merger with UK-based Absolute Antibody; the broader Vector portfolio also includes Everest Biotech, Exalpha Biologicals, Nordic-MUbio, and LifeSpan BioSciences. The company is private, has not raised institutional capital since 2016, and runs a lean organization of 11-50 employees with a digital-first, self-serve go-to-market motion and email/blog marketing channels.

KeraFAST firmographics

Firmographics
Name
KeraFAST
Legal name
Vector Laboratories, Inc.
Website
https://kerafast.com
Company type
Private
Founded year
2011
Operating status
Operating
Headcount range
1–10 employees
Short description
Kerafast is a Boston-based e-commerce marketplace enabling life science researchers worldwide to discover, purchase, and supply unique academic reagents, bypassing traditional MTA processes through a self-serve platform serving 200+ contributing institutions.
Ownership category
akta.pro rank

KeraFAST industry classification

Industry
Product category
Life Science Research Reagents
NAICS
Research and Development in Biotechnology (except Nanobiotechnology) (541714)
SIC
Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)
akta.pro industry
PRIMARYBPAMAGAL
Omnichannel Commerce & Click-and-Collect Platforms
Business & Public Services/Web, Mobile & Digital Platforms/E-commerce Marketplaces & Shopping Platforms

Keywords

  • Research reagent marketplace
  • Life science reagents
  • Antibody distribution
  • Virus vectors
  • Academic reagent supply

Where KeraFAST is headquartered

Location

Headquarters

HQ city
Boston
HQ country
United States
HQ region
North America

Offices2 records

Markets served

KeraFAST business model

Business model
GTM type
B2B
Offering type
Digital Commerce or Content
Cost components
Operations, Marketing or Sales, Technology or R&D, Personnel, Supply Chain

Revenue model

  1. Reagent Product Sales: Direct sales of research reagents including antibodies, cell lines, plasmids, lentiviruses, virus vectors, proteins, and other laboratory materials. Transaction-based pricing with listed catalog prices.
  2. Royalty Revenue Sharing: Generous royalty payments returned to scientists and institutions that contribute reagents to the platform, funded from every sale.

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goIndividual reagent products sold at catalog prices

Go-to-market motion1 record

Distribution channels2 records

Marketing channels3 records

KeraFAST product offering

Product offering

Core offering

KeraFAST operates an online marketplace that aggregates unique, hard-to-obtain research reagents contributed by academic laboratories worldwide and makes them directly purchasable by life science researchers. The platform bypasses traditional Material Transfer Agreement (MTA) processes, offering reagents across categories including antibodies, cell lines, plasmids, lentiviruses, VSV vectors, proteins, enzymes, and kits. Proceeds from sales are shared with contributing laboratories via a royalty model branded 'Reagents for the Greater Good'.

Product overview

KeraFAST is a Boston-based reagent company offering an extensive portfolio of unique research products sourced from university laboratories worldwide. The company operates as a multi-category reagent marketplace featuring over 11 product types including Antibodies & Secondary Detection Reagents, Buffers & Chemicals, Cell Culture & Transfection Reagents, Cells & Tissue Samples, DNA Vectors/Clones/Nucleic Acids, Kits & Assays, Labeling & Detection Products, PCR Products, Proteins/Enzymes/Peptides, Virus Vectors and Particles, and Services. Core product lines include Vesicular Stomatitis Virus (VSV) reagents (antibodies, cell lines, plasmids, pseudotyped viruses), Premade Lentiviruses, and the VSV-G Pseudotyped ΔG Virus System for producing chimeric viruses. The company also offers Custom Lentivirus Production services. Products are sourced from academic researchers and distributed through an online platform, with proceeds returning to the providing laboratories.

Differentiator

Problem solved

Functional benefit

Products and services

  • Antibodies & Secondary Detection Reagents Catalog of primary antibodies, secondary antibodies, antibody labeling reagents, tag and loading control antibodies, and hybridomas supplied by academic laboratories for life science research applications.
  • Buffers & Chemicals Laboratory buffers, compounds, isolated natural products, and unique chemistry reagents sourced from academic providers for research applications.
  • Cell Culture & Transfection Reagents Reagents for cell culture maintenance and genetic transfection experiments, distributed via the marketplace.
  • Cells & Tissue Samples Bacterial cells, eukaryotic cells, primary cells, stem cells, and tissue samples supplied by academic laboratories for research use.
  • DNA Vectors, Clones, Purified Nucleic Acids & Libraries GFP-dependent transcription system plasmids, general plasmids, and purified nucleic acid reagents for molecular biology research.
  • Kits & Assays Complete assay kits for various research applications, assembled from reagents contributed by academic laboratories.
  • Labeling & Detection Products Click chemistry probes, biotin-related reagents, fluorescent probes, nanoparticles, reactive dyes, GFP reagents, chelators, and protein conjugation kits for detection workflows.
  • PCR Products

Companies that use KeraFAST

Customer profile

Named customers6 records

Segments3 records

Ideal customer profiles3 records

KeraFAST technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature2 records

KeraFAST partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered core.

  • Absolute AntibodycoreStrategic or Co-development Partner · 1 January 2018UK-based company merged with Kerafast in 2018 with shared commitment to improving selection of research tools. Absolute Antibody focuses on recombinant antibody technology. Kerafast handles North and South American sales and customer service as well as global marketing for Absolute Antibody.
  • Vector LaboratoriescoreTechnology or IntegrationKerafast is owned and operated by Vector Laboratories Inc. Part of the Vector family including Everest Biotech, Exalpha Biologicals, Nordic-MUbio, LifeSpan BioSciences, Inc., and Absolute Antibody, Ltd.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

KeraFAST competitors and assessment

Company assessment

Direct peers

  • Addgene: Non-profit plasmid repository operating a similar community-driven reagent sharing model for life science researchers. Highly comparable as a peer-to-peer reagent exchange marketplace serving academic scientists, though Addgene focuses specifically on plasmids and associated tools.
  • Santa Cruz Biotechnology: Antibody and reagent supplier serving academic and pharmaceutical researchers across multiple research areas. Comparable as a direct competitor in antibody and reagent sales to life science researchers, with overlapping product categories.

Broad incumbents

  • ATCC (American Type Culture Collection): Established biological resource center offering authenticated cell lines, microorganisms, and related services. Comparable as a supplier of standardized biological materials to research institutions, though ATCC operates as a traditional distributor rather than a marketplace.
  • Thermo Fisher Scientific: Largest life science reagent and instrument supplier globally, offering extensive catalogs across antibodies, cell culture, and molecular biology products. Represents the dominant incumbent against which Kerafast's marketplace model competes for research reagent budgets.
  • Sigma-Aldrich (MilliporeSigma): Major chemical, biochemical, and reagent distributor under Merck KGaA. Comparable as a broad-line reagent supplier to academic and pharmaceutical researchers with established logistics and brand recognition.
  • Bio-Techne: Life science reagent and instrument provider spanning proteins, antibodies, ELISA kits, and cell/gene therapy workflow tools. Comparable as a multi-category reagent supplier serving academic and pharma researchers with overlapping product categories.
  • Abcam: Major specialty antibody supplier serving life science research. Comparable as a high-quality reagent distributor with strong academic customer base, though Abcam focuses on antibodies rather than operating a broad marketplace model.
  • Cell Signaling Technology: Specialty antibody and reagent provider for cell signaling research. Comparable as a research-grade reagent supplier with strong academic and pharma relationships, particularly in antibody products that overlap with Kerafast's catalog.

Others

  • Absolute Antibody: Recombinant antibody technology provider that merged with Kerafast in 2018 under Vector Laboratories. Comparable as a sister company operating within the same Vector Labs portfolio with overlapping customer base and shared infrastructure.

Emerging players

  • Coriell Institute for Medical Research: Non-profit biomedical research organization maintaining cell line and DNA repositories for the research community. Comparable as a specialized biorepository serving academic researchers, though Coriell is more focused on biobanking than an active marketplace.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

KeraFAST social profiles

Digital presence

KeraFAST financial estimates

Financial estimate

Revenue estimate

Valuation estimate

KeraFAST leadership team

Management profile

Number of profiles

Profiles1 record

KeraFAST funding detail

Funding detail

Funding overview

Funding rounds4 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

KeraFAST M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about KeraFAST

What does KeraFAST do?

KeraFAST operates an online marketplace that aggregates unique, hard-to-obtain research reagents contributed by academic laboratories worldwide and makes them directly purchasable by life science researchers. The platform bypasses traditional Material Transfer Agreement (MTA) processes, offering reagents across categories including antibodies, cell lines, plasmids, lentiviruses, VSV vectors, proteins, enzymes, and kits. Proceeds from sales are shared with contributing laboratories via a royalty model branded 'Reagents for the Greater Good'.

Is KeraFAST a public or private company?

KeraFAST is a private company. It is classified as corporate owned and is currently operating.

When was KeraFAST founded?

KeraFAST was founded in 2011. It employs 1 to 10 people.

Where is KeraFAST based?

KeraFAST is headquartered in Boston, United States, in the North America region.

How does KeraFAST make money?

Two revenue lines are on record. Reagent Product Sales are the primary driver. The others are royalty Revenue Sharing.

Who are KeraFAST's main competitors?

Direct peers on record are Addgene and Santa Cruz Biotechnology. Broad incumbents are ATCC (American Type Culture Collection), Thermo Fisher Scientific, Sigma-Aldrich (MilliporeSigma), Bio-Techne, Abcam and Cell Signaling Technology. Absolute Antibody is listed as an others. Coriell Institute for Medical Research is listed as an emerging player.

Does KeraFAST have an API?

No public API is recorded for KeraFAST.

What industry is KeraFAST in?

KeraFAST's product category is Life Science Research Reagents. Its primary akta.pro industry code is BPAMAGAL, Omnichannel Commerce & Click-and-Collect Platforms. Its NAICS code is 541714 and its SIC code is 5122.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
The GuardianSecrets and pies: the battle to get lab-grown meat on the menuResearchers in the cellular agriculture industry face a significant hurdle due to the lack of publicly available cell lines, as private companies keep proprietary discoveries behind closed doors to protect their intellectual property. The Good Food Institute is addressing this gap by funding the creation of openly accessible cell lines through a repository managed by Kerafast, while only $12 million of the $366 million invested in cultured meat in 2020 came from public sources. In December, Eat Just became the first company to gain regulatory approval for its cultured chicken in Singapore, but industry-wide adoption of cheaper alternatives to expensive foetal bovine serum remains hindered by trade secrets.FinSMEsLSBio Acquires Absolute Antibody Ltd.LSBio acquired UK-based Absolute Antibody and its sister company Kerafast, with terms undisclosed. The deal adds recombinant antibody services and a catalog of engineered antibodies to LSBio's portfolio. The acquisition aligns with LSBio's goal of providing validated, reproducible antibodies for research.GlobeNewswirePressure BioSciences, Inc. and KeraFAST LLC Sign Worldwide E-Commerce Distribution DealPressure BioSciences and KeraFAST signed a non-exclusive worldwide distribution agreement for several sample preparation products, including the SHREDDER SG3 Extraction System and proprietary kits for DNA, RNA, protein, and lipid analysis. KeraFAST will distribute these products through its e-commerce channels, aiming to increase PBI's market share.